Medical Specialties > Interventional Cardiology > Multi Vessel Disease

Multi Vessel Disease 

Ensure cost-efficiency in your Multi-vessel Disease cases.

Multi-vessels coronary artery disease (CAD) is a disease stage in which at least two or three of the epicardial coronary arteries is involved with atherosclerosis of significant severity.

The goal in the treatment of multi-vessel disease is to reduce angina and heart failure symptoms.

The FAME study demonstrated that routine measurement of FFR (Fractional Flow Reserve) during DES-stenting in patients with multi-vessel disease is superior to current angiography guided treatment and improves outcome of PCI significantly.

From a short time, we also see some non Hyperemic index's been developed such as DFR™.  The goal of these indexs are to avoid injection of adenosine. It may reduce cost and duration procedure. It also may lead to assess patient who are contraindicated to FFR.

 View case study on PCR online

CASE STUDY

Innovations in complex multivessel disease PCI – SYNTAX II strategy and beyond

Get to know COMET™

PRODUCT HIGHLIGHT

COMET™ Pressure Guidewire:
Now displaying DFR™

Diastolic pressure ratio: new approach and validation

CLINICAL EVIDENCE

Diastolic pressure ratio: new approach and validation vs. the instantaneous wave-free ratio

PCR Syntax II Symposium

PCR SYMPOSIUM

PCR SYNTAX II Symposium & Webinar

SYNTAX II Trial Data

CLINICAL EVIDENCE

The SYNTAX II Trial evaluated the SYNERGY™ BP-EES Stent in a procedure-related trial

Synergy

PRODUCT HIGHLIGHT

SYNERGY™ Coronary Stent System: Designed to promote optimal healing

Join our Complex PCI Community

Join our Complex PCI Community

Stay up-to-date via email on the latest advances in complex PCI

Button
Elevate your Education

Elevate your education

Explore EDUCARE, our globally recognised education programme

Button
Talk to a representative

Talk to a representative

Want to learn more about products and services? One of our sales representatives will be happy to contact you.

Button
Top